✦ LIBER ✦

BRAF inhibition and beyond in advanced melanoma

✍ Scribed by Kim Margolin

Book ID: 117310526
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 752 KB
Volume: 380
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(12)60993-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined BRAF and MEK Inhibition versus

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

✍ Long, Georgina V.; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Br 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 570 KB

Recent advances in melanoma systemic the

Recent advances in melanoma systemic therapy. BRAF inhibitors, CTLA4 antibodies and beyond

✍ Menzies, Alexander M.; Long, Georgina V. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 819 KB

Resistance to BRAF Inhibition in Melanom

Resistance to BRAF Inhibition in Melanomas

✍ Solit, David B.; Rosen, Neal 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 172 KB

Combined BRAF and MEK Inhibition in Mela

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

✍ Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Ri 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 528 KB

Combined BRAF and MEK Inhibition in Mela

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

✍ Flaherty, Keith T.; Infante, Jeffery R.; Daud, Adil; Gonzalez, Rene; Kefford, Ri 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 528 KB

## Background Resistance to therapy with BRAF kinase inhibitors is associated with reactivation of the mitogen-activated protein kinase (MAPK) pathway. To address this problem, we conducted a phase 1 and 2 trial of combined treatment with da braf e nib, a selective BRAF inhibitor, and trametinib, a

Combined inhibition of BRAF and MEK in m

Combined inhibition of BRAF and MEK in melanoma patients

✍ Infante, Jeffrey R; Swanton, Charles 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 212 KB